POINT Biopharma - Accelerating Precision Medicine
We are a next generation radiopharmaceutical company, taking cancer head on. We are pushing forward the next-generation of radiopharmaceuticals with our exciting pipeline. Radiopharmaceutical products could offer new hope to patients with cancer. With focus and precision, our products direct the power of high energy particles towards cancer - and only cancer.
This company is:
Verified
PIRI: POINT Institute for Radioligand Innovation
Located in Toronto, Ontario PIRI is POINT's radioligand research and development facility.
Verified
Our Clinical Pipline | POINT Biopharma
We have a diverse pipeline of exciting radiopharmaceuticals targeting both specific indications like prostate cancer, as well as pan-tumor targets like FAP-α.
Verified
Clinical Trials | POINT Biopharma
Learn more about POINT’s current clinical trials exploring new radioligand and radiopharmaceutical therapies.
View all products
Keywords
Industries
Where is Point Biopharma located?
The company Point Biopharma is located in Indianapolis, Indiana, United States. It's worth noting that the company may has more corporate locations
How many employees does Point Biopharma approximately have?
As of the latest available information Point Biopharma has around 11-50 employees worldwide.
When was Point Biopharma founded?
Point Biopharma was founded in 2017
In which industries does Point Biopharma mainly work?
The company Point Biopharma has it's main focus in the industries of Biotechnology
Applied Molecular Therapies
Australia
51-100 Employees
2021
View
RayzeBio
United States
11-50 Employees
2018
View
Fusion Pharmaceuticals
Canada
11-50 Employees
2014
View
Aktis Oncology
United States
1-10 Employees
2021
View
IsoRay
United States
11-50 Employees
1998
View
NorthStar Medical Radioisotopes
United States
51-100 Employees
2006
View
SmART Scientific Solutions B.V.
Netherlands
1-10 Employees
2015
View
IASON GmbH
Austria
11-50 Employees
1996
View
Topics which have been searched by others and may be interesting for you:
